Inventive steps: the CRISPR patent dispute and scientific progress
Sign Up to like & getrecommendations! Published in 2017 at "EMBO reports"
DOI: 10.15252/embr.201744418
Abstract: Recent decisions by patent offices in the USA and Europe concerning the revolutionary gene‐editing technology, CRISPR/Cas9, have shed light on the importance—and puzzles—of one particular area of patent law: “nonobviousness”, as it known in the… read more here.
Keywords: work; european patent; doudna charpentier; broad institute ... See more keywords